BELVIQ for weight loss

Belviq_DFB_pg1.PNG
Belviq_DFB_pg1.PNG

BELVIQ for weight loss

0.00

BELVIQ was approved in 2012 for weight loss. The DrugFactsBox shows results for people without diabetes and for people with diabetes. 

Without diabetes: FDA reviewed two trials with a total of 6,136 people without diabetes. Most were women, ages 18 to 65 years, with an average weight of 221 pounds, who were either overweight and had weight-related health problems or were obese. They were randomized to either BELVIQ or PLACEBO for 1 year. Get the DrugFactsBox to see what happened. 

With diabetes: FDA reviewed a trial with 499 men and women with diabetes. They were between the ages of 18 to 65 years, with an average HbA1c of 8% and an average weight of 228 pounds, and were either overweight and had weight-related health problems or were obese. They were randomized to either BELVIQ or PLACEBO for 1 year. Get the DrugFactsBox to see what happened. 

Read about Consumer Reports' take on BELVIQ here.

Add To Cart